$1.44
0.04[2.86%]
At close: Apr 17
$1.44
0[0.00%]
After Hours: 8:15AM EDT
Exagen Stock (NASDAQ:XGN), Analyst Ratings, Price Targets, Predictions
Exagen Inc has a consensus price target of $8.75, established from looking at the 9 latest analyst ratings. The last 3 analyst ratings were released from Cantor Fitzgerald, Cantor Fitzgerald, and Cantor Fitzgerald on September 26, 2023, August 22, 2023, and May 16, 2023. With an average price target of $6 between Cantor Fitzgerald, Cantor Fitzgerald, and Cantor Fitzgerald, there's an implied 328.57% upside for Exagen Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
BTIG
Canaccord Genuity
Keybanc
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Exagen
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 09/26/2023 | XGN | Buy Now | Exagen | $1.40 | 328.57% | Cantor Fitzgerald | Ross Osborn | → $6 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | XGN | Buy Now | Exagen | $1.40 | 328.57% | Cantor Fitzgerald | Ross Osborn | → $6 | Reiterates | Overweight → Overweight | Get Alert |
| 05/16/2023 | XGN | Buy Now | Exagen | $1.40 | 328.57% | Cantor Fitzgerald | Ross Osborn | → $6 | Reiterates | Overweight → Overweight | Get Alert |
| 03/22/2023 | XGN | Buy Now | Exagen | $1.40 | 257.14% | BTIG | Mark Massaro | $6 → $5 | Maintains | Buy | Get Alert |
| 11/17/2022 | XGN | Buy Now | Exagen | $1.40 | 400% | BTIG | Mark Massaro | $10 → $7 | Maintains | Buy | Get Alert |
| 11/15/2022 | XGN | Buy Now | Exagen | $1.40 | 400% | Canaccord Genuity | Kyle Mikson | $8 → $7 | Maintains | Buy | Get Alert |
| 05/13/2022 | XGN | Buy Now | Exagen | $1.40 | 1114.29% | Keybanc | Paul Knight | $20 → $17 | Maintains | Overweight | Get Alert |
| 03/25/2022 | XGN | Buy Now | Exagen | $1.40 | 1328.57% | Keybanc | Paul Knight | $30 → $20 | Maintains | Overweight | Get Alert |
| 11/11/2021 | XGN | Buy Now | Exagen | $1.40 | 2042.86% | Keybanc | Paul Knight | — | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Exagen (XGN)?
The latest price target for Exagen (NASDAQ: XGN) was reported by Cantor Fitzgerald on September 26, 2023. The analyst firm set a price target for $6.00 expecting XGN to rise to within 12 months (a possible 316.67% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Exagen (XGN)?
The latest analyst rating for Exagen (NASDAQ: XGN) was provided by Cantor Fitzgerald, and Exagen reiterated their overweight rating.
When was the last upgrade for Exagen (XGN)?
There is no last upgrade for Exagen.
When was the last downgrade for Exagen (XGN)?
There is no last downgrade for Exagen.
When is the next analyst rating going to be posted or updated for Exagen (XGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exagen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exagen was filed on September 26, 2023 so you should expect the next rating to be made available sometime around September 26, 2024.
Is the Analyst Rating Exagen (XGN) correct?
While ratings are subjective and will change, the latest Exagen (XGN) rating was a reiterated with a price target of $0.00 to $6.00. The current price Exagen (XGN) is trading at is $1.44, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.